Battling against radiotherapy-induced immune tolerance in colorectal cancer: potential synergistic effects of VISTA and CD39 inhibitors

aDepartment of Urology, Zhongda Hospital, Southeast University

bSurgical Research Center, Institute of Urology, Southeast University Medical School

cDepartment of General Surgery, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University

dDepartment of General Surgery, The Second Hospital of Chinese Medicine, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China

Received 15 September 2023 Accepted 26 September 2023.

Correspondence to: Tianhang Li, PhD, Department of Urology, Zhongda Hospital, Southeast University, Nanjing 210009, China, Tel: +86-83949558; e-mail: [email protected]

留言 (0)

沒有登入
gif